Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
Panke Qu(The Ohio State University), Shan‐Lu Liu(University of Missouri), Lianbo Yu(The Ohio State University), John P. Evans(The Ohio State University), Julia N. Faraone(The Ohio State University), Claire Carlin(The Ohio State University), Linda J. Saif(The Ohio State University), Richard J. Gumina(The Ohio State University Wexner Medical Center), Eugene M. Oltz(Washington University in St. Louis), Gerard Lozanski(The Ohio State University Wexner Medical Center), Yi-Min Zheng(University of Missouri), Qin Ma(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 86
Related Papers
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG)
|Archives of Virology|2011|998
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments
|Archives of Virology|2008|769
IFITM Proteins Restrict Viral Membrane Hemifusion
|PLoS Pathogens|2013|368
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
|Cell Host & Microbe|2022|280